The opposite has been shown in a mouse model for Huntington's disease (HD), where astrocytic GABA release through GABA transporter 3 (GAT-3) is reduced, resulting in reduced tonic inhibition in striatal output neurons 192. Here, SLC6A11 is linked to juvenile Huntington disease.